Advanced Workshop | Berlin
2022
Jun
9th—10th
2022
DRUG RESEARCH & DEVELOPMENT: CONTEMPORARY CHALLENGES AND SOLUTIONS
The workshop addresses experts working in preclinical and clinical development who would like to share perspectives in deciding the best clinical development strategy using adaptive & innovative designs and implementing new technologies. Based on the suggestions of the participants a selection of presentations will be made. To support networking, the number of participants is limited to 36 persons.
BRIDGING THE GAP BETWEEN OFFLINE AND ONLINE NETWORKING:
group exclusively for former and prospective participants in the event series
REGISTRATION
Free of charge (on invitation only – please contact organizers for further details)
LOCATION
CoLaborator Berlin | Müllerstr. 178, 13353 Berlin
ORGANIZERS
| Dr. Klaus Francke Bayer AG |
| Dr. Ekkehard May Nuvisan – Innovation Campus Berlin (ICB) |
| Dr. Grit Zahn Eternygen GmbH |
| Dr. Frank S. Zollmann Pharma Consult, CONELIS e.V. |
June 9th 2022
| Time | |
| 14:00 | Arrival |
| 15:30 | Explore the Campus Wedding
Introduction to Innovation Campus Berlin (ICB) and Start-ups represented in the CoLaborator |
| 18.30 | Come together @ CoLaborator
Potluck buffet, sports (table tennis, volleyball), music by Pedro Isoni (iso*)
|
June 10th 2022
| Time | |
| 07:30 | Registration |
| 08:45 | Welcome Address and Introduction into the Workshop |
| 09:00 | Individual Introduction of the Participants |
| 09:45 | Focus on Preclinical Research
Martin Lange: Biomarkers for oncology drug development Ekkehard May: Indication evaluation |
| Coffee Break |
|
| 10:45 | Focus on Clinical Development
Stefan Jodl: Study design to explore PD in an early development candidate Maximilian Posch: Dose escalation in FTIH studies – adaptive approaches Jörg Taubel: Experiences of a London based first in human principal investigator Natalia Mühlemann: Managing uncertainties and making trade-off decisions: how to maximize the use of your statisticians Matthias Mohse: Front-loading of early clinical trials to support decision-making and accelerated development |
| 12:00 | Business models
Maarten de Château: The story of Cormorant Pharmaceuticals |
| Lunch Break |
|
| 14:00 | Meet the Future
Ilka Maschmeyer & Eva-Maria Dehne: Applying Multi-Organ-Chip Technology in Safety and Efficacy Testing: Progress and Challenges Altuna Akalin: AI for developing better oncology therapeutics Marco Schmidt: Causal inference to predict clinical outcome based on genome-wide association data |
| 15:15 | Workshop 2023
Brainstorming |
| Coffee Break |
|
| 15.30 | Closing |